Grünenthal Enhances Global Regulatory Information Management with Veeva RIM

Grünenthal, a global leader in pain management, is revolutionizing its regulatory organization by implementing Veeva RIM (Regulatory Information Management). On June 25, 2025, Veeva Systems, a prominent cloud software provider, announced this significant advancement, which aims to streamline regulatory processes, promote standardization, and improve collaboration within the organization.

With Veeva RIM, Grünenthal is taking its regulatory information management to new heights, enabling faster responses to regulatory changes and enhancing the efficiency of processes ranging from submission planning to tracking approvals and decisions. According to Argha Nag, Vice President and Head of Digital Transformation for RIM and R&D at Grünenthal, "By utilizing Veeva RIM, Grünenthal is transforming and simplifying its global regulatory processes, enhancing oversight and data visibility, and fostering better collaboration within the organization to ultimately deliver safe and effective medications to patients."

The unification of data silos through Veeva’s cloud platform allows Grünenthal's teams to focus on more strategic activities. This transformation not only augments data oversight but also fosters greater efficiency in workflows, thereby streamlining the entire regulatory process. The unified application enables teams to meet regulatory requirements effectively and ensures continued global compliance.

Paul Attridge, Veeva's Vice President of RIM, remarked, "Veeva RIM provides Grünenthal with the unified data and workflow platform necessary for a better understanding of its regulatory processes. This increased visibility and control will enable quicker and more informed decisions, accelerating the delivery of essential pain treatments to patients."

The implementation of Veeva RIM is part of Veeva Development Cloud, which serves as the technological backbone for product development. This comprehensive cloud suite amalgamates clinical, quality, regulatory, and safety applications to simplify end-to-end business processes and ensure process excellence in the life sciences sector.

Grünenthal's shift to Veeva RIM highlights a growing trend in the biopharmaceutical industry, where organizations are increasingly turning to cloud-based solutions to enhance operational efficiency. By centralizing regulatory information management, Grünenthal positions itself to better respond to the changing regulatory landscape, ensuring that it can bring pain relief therapies to those in need swiftly.

For more details on Veeva RIM, you can visit veeva.com/eu/VeevaRIM and connect with Veeva on LinkedIn.